About Us OncoTartis, Inc. is a private biotechnology company established in 2011. Company's founding IP came from Prof. Andrei Gudkov's laboratory at Roswell Park Cancer Institute (Buffalo, NY). OncoTartis develops a novel category of anti-cancer drugs directed against tissue-specific targets for a subset of cancers (breast, prostate, ovarian,
http://www.oncotartis.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
6.6 seconds
Tartis, Inc
Alexander Polinsky
73 ●●● St
Bu●●lo , NY, 14203
US
View this contact
Tartis, Inc
Alexander Polinsky
73 ●●● St
Bu●●lo , NY, 14203
US
View this contact
1&1 Internet Inc.
Hostmaster ONEANDONE
701 ●●●● Rd.
Ches●●●●rook , PA, 19087
US
View this contact
BUY YOUR DOMAIN
11
YEARS
4
MONTHS
23
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
0
SITE IP
74.208.236.182
LOAD TIME
6.594 sec
SCORE
6.2
OncoTartis – Treating ONCOlogical diseases by TARgeting TISsue-specific Achilles heels of cancer | oncotartis.com Reviews
https://oncotartis.com
About Us OncoTartis, Inc. is a private biotechnology company established in 2011. Company's founding IP came from Prof. Andrei Gudkov's laboratory at Roswell Park Cancer Institute (Buffalo, NY). OncoTartis develops a novel category of anti-cancer drugs directed against tissue-specific targets for a subset of cancers (breast, prostate, ovarian,
oncotartis.com
News - OncoTartis Website
http://oncotartis.com/6.html
February 17, 2011. OncoTartis, Inc. is incorporated as a NY corporation located in Buffalo, NY. Roswell Park Cancer Institute (RPCI) and. Children's Cancer Institute Australia (CCIA). Contributed founding IP and are shareholders of the company. Moscow, Russia is a financial investor that committed a funding sufficient to support OncoTartis, Inc. operations for 3 years. January 30, 2012. The Grant Committee of. February 27, 2013. May 1, 2013. Skolkovo Foundation approves the second tranche of. May 16, 2014.
Contact - OncoTartis Website
http://oncotartis.com/9.html
640 Ellicott St,. Buffalo, NY 14203.
Pipeline - OncoTartis Website
http://oncotartis.com/4.html
Details of OT-82 program.
Team - OncoTartis Website
http://oncotartis.com/2.html
Founder, President and CEO. PhD in Physical Chemistry, Moscow State University. UCSD, Visiting Scholar. Alanex Coporation, Founder, CSO. Agouron Pharmaceuticals, VP Drug Discovery. Pfizer, VP Drug Discovery Technologies, La Jolla Labs. Pfizer, VP Global R&D, External Research Network. Pfizer, VP Global R&D, CEO of The Pfizer Incubator. Everon Biosciences, Founder, President and CEO. PhD in Experimental Oncology, Cancer Research Center, Moscow. DSci in Molecular Biology, Moscow State University.
About OncoTartis - OncoTartis Website
http://oncotartis.com/index.html
Is a private biotechnology company established in 2011. It is located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus. It has a strategic partnership with Roswell Park Cancer Institute. Where the original intellectual property was developed in the laboratory of Professor Andrei Gudkov. To rev olutionize treatment of a. OncoTartis is exploring a proprietary drug discovery approach called TARTIS. An anti-AML candidate,. Against broad range of leukemias and lymphomas. Efficacy s...
TOTAL PAGES IN THIS WEBSITE
6
Oncotarget
To ensure proper functionality of this site, both JavaScript and Cookies. Must be enabled in your browser. Welcome to Oncotarget, please log in. New authors should register for an account. Forgotten Login and Password. Licensed under Patent #US 7,620,555B1.
Oncobiology and Targets - Free full text articles from Oncobiology and Targets
September-October 2014 Vol 1 Issue 1. Letter from the Editor: Launching "Oncobiology and Targets". At the launch of its inaugural issue, I would like to share some thoughts on how through Oncobiology and Targets we are starting a unique publishing approach that is drastically different from multitu. Mobile HTML Full text]. The tumor microenvironment as a target for anticancer treatment. Mobile HTML Full text]. Lectins-the promising cancer therapeutics. Mobile HTML Full text]. Mobile HTML Full text].
OncoTartis – Treating ONCOlogical diseases by TARgeting TISsue-specific Achilles heels of cancer
Logical diseases by TAR. Sue-specific Achilles heels of cancer. OncoTartis is exploring a proprietary drug discovery approach called TARTIS (TARTIS = TAR. Sue) TARTIS is designed to develop small molecules for treatment of malignancies originating from specific tissues that are either non-essential for the general viability of mammalian organism (i.e., gender-associated tissues or melanocytes) or can be effectively replaced (hematopoietic system). TARTIS technology involves screening of chemi...
Cartas de nós
Manifestações de encanto e de saudade. Depoimentos de porquarianos e porquarianas, que com suas histórias são as histórias do grupo! Sábado, 12 de janeiro de 2008. Bem, minha experiência no Por Quá. Foi o tiro para eu começar a seguir a minha carreira de produtora cultural. De uma menina cheia de caretas e com a rebeldia presa,. Fez-se estourar, através de simples passos,. Provando que todos podem dançar, voar, criar. Veio a dança,. Confirmação do meu amor a arte. Deixei muitas amarras de adolescente,.
Coming Soon - Future home of something quite cool
Future home of something quite cool. If you're the site owner. To launch this site. If you are a visitor. Please check back soon.
Intersaar GmbH Mailarchiv
Intersaar GmbH Mailarchiv
Oncotherm
